Nonproprietary name and trademarks of drug
AvRuskin, T.W.; Lala, V.; Tang, S.C.; Juan, C.S.
American Journal of Diseases of Children 133(5): 553-555
1979
ISSN/ISBN: 0002-922X PMID: 433881 Document Number: 140187
Document emailed within 1 workday
Related Documents
Pestova, A.G. 1975: Experimental findings concerning the migrational capacity of chemicals from plastic foams with trademarks FRP-1, FRP-4 and PPP-309 Gigiena i sanitariia 1975(1): 23-26Hashiba, S.; Takenaka, Y.; Nakadate, M. 1989: Development of the database on nonproprietary names of drugs Eisei Shikenjo Hokoku. Bulletin of National Institute of Hygienic Sciences 1989(107): 141-145
Polk, B. 2004: International nonproprietary names. How it begins and what it asserts Medizinische Monatsschrift für Pharmazeuten 27(11): 373-6; Quiz 377-8
Andersson, M.L.; Böttiger, Y.; Lindh, J.D.; Wettermark, B.; Eiermann, B. 2013: Impact of the drug-drug interaction database SFINX on prevalence of potentially serious drug-drug interactions in primary health care European Journal of Clinical Pharmacology 69(3): 565-571
Nishikaze, O. 1975: Drug-drug interaction and drug-induced interference with clinical laboratory test procedures--chairman's introductory remarks Rinsho Byori. Japanese Journal of Clinical Pathology 23(2): 75
Matsuda, T. 1993: Antithrombotic drug (thrombolytic drug, anticoagulant, antiplatelet drug) Nihon Rinsho. Japanese Journal of Clinical Medicine 51 Suppl: 179-185
Kohl, C.; Steinkellner, M. 2000: Prediction of pharmacokinetic drug/drug interactions from in vitro data: interactions of the nonsteroidal anti-inflammatory drug lornoxicam with oral anticoagulants Drug Metabolism and Disposition: the Biological Fate of Chemicals 28(2): 161-168
Rabinovich, S.A. 1976: Drug resistance of malaria parasites. 2. Clinical aspects, drug treatment and prevention of drug-resistant malaria Meditsinskaia Parazitologiia i Parazitarnye Bolezni 45(6): 731-737
Siest, G.; Delwaide, P.; Malya, P.A.G.; Breuer, H.; Galteau, M.M.; Salway, J.G.; Tognoni, G.; Tryding, N. 1988: International Federation of Clinical Chemistry, Scientific Committee: Drug interferences and drug effects in clinical chemistry. Part 6. Laboratory tests in monitoring drug administration Journal of Clinical Chemistry and Clinical Biochemistry 26(3): 181-186
Garfein, R.S.; Swartzendruber, A.; Ouellet, L.J.; Kapadia, F.; Hudson, S.M.; Thiede, H.; Strathdee, S.A.; Williams, I.T.; Bailey, S.L.; Hagan, H.; Golub, E.T.; Kerndt, P.; Hanson, D.L.; Latka, M.H. 2007: Methods to recruit and retain a cohort of young-adult injection drug users for the Third Collaborative Injection Drug Users Study/Drug Users Intervention Trial (CIDUS III/DUIT) Drug and Alcohol Dependence 91(Suppl 1): S4-17
Horváth, Z. 1973: Studies on the causes for drug abuse using ethylmorphine hydrochloride and acetylsalicylic-acid-containing drug combinations Die Pharmazie 28(4): 242-243
Fujii, Y. 2001: Acute phase drug therapy and drug switching in the treatment of patients with schizophrenia Seishin Shinkeigaku Zasshi 103(12): 1030-1035
Merlin, Béatrice.; Chazard, E.; Pereira, S.; Serrot, E.; Sakji, S.; Beuscart, Régis.; Darmoni, S. 2010: Can F-MTI semantic-mined drug codes be used for adverse drug events detection when no CPOE is available? Studies in Health Technology and Informatics 160(Pt 2): 1025-1029
Pedersen, P.A. 1975: Drug legislation and drug evaluation. Important aspects discussed in West Germany Ugeskrift for Laeger 137(6): 333-335
Ayala, R.C.; Arya, V.; Younis, I.R. 2016: Design Features of Drug-Drug Interaction Trials Between Antivirals and Oral Contraceptives Journal of Clinical Pharmacology 56(5): 541-547
Thakore, J.H.; Mann, J.N.; Vlahos, I.; Martin, A.; Reznek, R. 2002: Increased visceral fat distribution in drug-naive and drug-free patients with schizophrenia International Journal of Obesity and Related Metabolic Disorders: Journal of the International Association for the Study of Obesity 26(1): 137-141
Jackevicius, C.A.; Tu, K.; Filate, W.A.; Brien, S.E.; Tu, J.V. 2003: Trends in cardiovascular drug utilization and drug expenditures in Canada between 1996 and 2001 Canadian Journal of Cardiology 19(12): 1359-1366
Kamya, M.R.; Bakyaita, N.N.; Talisuna, A.O.; Were, W.M.; Staedke, S.G. 2002: Increasing antimalarial drug resistance in Uganda and revision of the national drug policy Tropical Medicine and International Health: Tm and Ih 7(12): 1031-1041
Bresnahan, K.; Zuckerman, B.; Cabral, H. 1992: Psychosocial correlates of drug and heavy alcohol use among pregnant women at risk for drug use Obstetrics and Gynecology 80(6): 976-980
Pathak, J.; Kiefer, R.C.; Chute, C.G. 2013: Using linked data for mining drug-drug interactions in electronic health records Studies in Health Technology and Informatics 192: 682-686